• 🌎 Worldwide
    • 🇺🇸 U.S.
    • 🇨🇦 Canada
    • 🇬🇧 United Kingdom
    • 🌏 Asia
    • 🌍 Europe
    • 🌎 Latin America
    • 🌏 Oceania and Australasia
The Daily Marijuana Observer
SUBSCRIBE
  • Home
  • Latest
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
  • Home
  • Latest
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
No Result
View All Result
Home Investments Marijuana Stocks

3 Analysts are Bullish on an Israeli Cannabinoid-Based Pharma Company

Steven Lachard by Steven Lachard
August 20, 2018
in Israel, Marijuana Stocks, Trading
Israeli Marijuana Stock News
406
SHARES
ShareShare

This week, three different analysts have released ‘buy’ ratings on shares of Israeli cannabinoid-based biotechnology company Intec Pharma Ltd. (NASDAQ:NTEC).

H.C. Wainwright

H.C. Wainwright’s Managing Director of Equity Research Raghuram Selvaraju just assigned a ‘buy’ rating on shares of Intec alongside a price target of $16 USD per share. With a last traded price of $4.18 USD per share, H.C. Wainwright’s price target represents approximately 182% of potential upside.

Maxim Group

Maxim Group’s Senior Managing Director Jason McCarthy, Ph.D. just assigned a ‘buy’ rating on shares of Intec alongside a price target of $12 USD per share. With a last traded price of $4.18 USD per share, Maxim Group’s price target represents approximately 87% of potential upside.

Oppenheimer

Oppenheimer’s Senior Analyst Jay Olson just assigned a ‘buy’ rating on shares of Intec alongside a price target of $15 USD per share. With a last traded price of $4.18 USD per share, Oppenheimer’s price target represents approximately 158% of potential upside.

Context

On August 15th, Intec Pharma Ltd. announced financial results for the three and six months ended June 30, 2018 and provided a corporate update. Highlights of the company’s Q2 included:

  • Global enrollment reached more than 400 of the projected 420 patients into the Phase 3 ACCORDANCE clinical trial of Accordion Pill Carbidopa/Levodopa (AP-CD/LD) for the treatment of advanced Parkinson’s disease patients;
  • Completed enrollment at the European and Israeli sites in the ACCORDANCE clinical trial with the balance of the study’s patients to be recruited from the trial’s U.S. clinical sites;
  • More than 85% of eligible patients from the ACCORDANCE clinical trial are opting to participate in the Open Label Extension (OLE) study;
  • Created a Scientific Advisory Board (SAB) comprised of internationally renowned scientists, whose mission will be to provide scientific and clinical advice on the advancement of AP-cannabinoids in various indications;
  • Multiple poster presentations accepted at the upcoming International Parkinson and Movement Disorder Society (MDS) bi-annual meeting taking place October 5-9, 2018;
  • Appointed Brad Hayes, former Executive Vice President, Chief Financial Officer and Treasurer of Laboratory Corporation of America (LabCorp), to the Company’s Board of Directors;
  • Voluntarily filed for and completed de-listing from the Tel Aviv Stock Exchange, with NASDAQ Capital Market now the sole trading exchange; and
  • Raised gross proceeds of approximately $37.5 million in an underwritten public offering of 6.75 million ordinary shares and 400,000 ordinary shares following the partial exercise of the underwriters’ over-allotment option.
Want analyst alerts in your inbox as they’re released?
Sign up for D/M/O Pro Analyst Updates here.

Share this:

  • Click to email this to a friend (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on Tumblr (Opens in new window)
  • Click to share on Pocket (Opens in new window)
Tags: H.C. WainwrightIntec Pharma Ltd.Maxim GroupNASDAQ:NTECOppenheimer & Co. Inc.

Get Real-Time Updates from MJobserver.com

Unsubscribe
Steven Lachard

Steven Lachard

Steven Lachard is a staff writer for MJobserver.com with a particular focus on marijuana stocks. Beyond MJobserver.com, Steven's pot stock insights have been featured on TalkMarkets.com and more.

Related Posts

Cannabis Stocks News
Investments

GrowGeneration Announces $35,000,000 Follow-On Public Offering

June 10, 2020
Tilray Cannabis Cultivation Facility - Marijuana Stocks News
Events

Tilray, Inc. to Participate in Two Upcoming Virtual Investor Events

June 8, 2020
Cowen Conference Badge
Events

Intec Pharma to Participate at Three Investment Conferences in March

February 25, 2020
Acreage Announces Initial Close of Previously Announced Credit Facility and Loan Transaction
Investments

Intec Pharma Announces $10 Million Ordinary Shares Purchase Agreement With Aspire Capital

December 3, 2019
GW Pharmaceuticals Plc (NASDAQ: GWPH) Cannabis Stock News
PRO

PRO: Oppenheimer Cuts Price Target for Shares of GW Pharmaceuticals

September 27, 2019
Oppenheimer & Co. Inc. Marijuana Stocks
PRO

PRO: Oppenheimer Reiterates Hold Rating on Tilray Stock

September 26, 2019
Load More
Next Post
Rob Sands - Constellation Brands CEO

Constellation Brands CEO Says Cannabis Industry Poised for Tremendous Growth

Leave a Comment! Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

🚨 Subscribe to Stock Alerts

Get Live Updates on Breaking News

Subscribe Now

✉️ Subscribe to Our Newsletter!

* indicates required

🔎 Search Marijuana Stocks

📰 Recent News

  • Verano Holdings Enters into Agreement to Expand Arizona Footprint
  • Green Thumb Industries Announces Initial Public Offering in the U.S. to Raise US$100,000,000
  • Greenlane Announces Dismissal of Remaining Securities Class Action
  • Indiva Reports Record Market Share for January 2021
  • Acreage Announces Fourth Quarter And Full Year 2020 Earnings Date
Facebook Twitter Instagram LinkedIn Youtube

Cannabis News by Region

  • 🇺🇸 United States
  • 🇨🇦 Canada
  • 🇬🇧 United Kingdom
  • 🌏 Asia
  • 🌍 Europe
  • 🌎 Latin America
  • 🌏 Oceania and Australasia

Cannabis Tools & Resources

  • 📅 Calendar
  • 📊 Databases
  • 📇 Directories
  • 🔔 RSS Feeds
  • 📺 Videos

Find Cannabis Business Services

  • ⚖️ Attorneys & Law Firms
  • 📊 Accountants & Accounting Firms
  • 💡 Consultants & Consulting Firms
  • 📲 Marketing Agencies & Firms

The Daily Marijuana Observer

  • Subscribe
  • About MJobserver.com
  • Affiliate Marketing Disclosure
  • Legal Disclaimer
  • Privacy Policy
  • Contact Us

Advertise with Us

  • 👀 Advertise
  • 📣 DMO Newswire
  • 📇 List in Our Databases

© 2018 - 2021 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observer™ (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

No Result
View All Result
  • Home
  • Latest
  • 🔒 PRO
    • 🔒 A.M. Watchlist
    • 🔒 Analyst Action
  • 💼 Business
  • 📈 Investments
    • 📈 Stocks
    • 💰 ETFs and Funds
    • 💭 Market Commentary
    • 📰 Press Releases
    • 📅 Earnings Calendar
  • ⚖️ Law
    • Laws
    • Politics
    • Intellectual Property
    • Attorneys & Law Firms Database
  • 👥 People
    • ⚽ Athletes
    • 💼 Executives
    • 🌟 Celebrities
    • 🛒 Consumers
    • ⚕️ Doctors
    • 💊 Patients
  • 💊 Health
  • 📇 Databases
    • 📈 Stock Databases
    • 💰 Fund Databases
    • 💼 Service Providers Databases
    • 🏦 Marijuana Stock Brokers
    • 💲 Marijuana Cryptocurrencies

© 2018 - 2021 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observer™ (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

Login to your account below

Forgotten Password? Sign Up

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.